Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Pasini

Showing results (61-70 of 96) with videos related to

Pageof 10
Sort By:
American Journal of Medical Genetics|January 25, 2002
High prevalence of the G101W germline mutation in the CDKN2A (P16(ink4a)) gene in 62 Italian malignant melanoma familiesMichela Mantelli, Monica Barile, Paola Ciotti, et al.
European Journal of Human Genetics : EJHG|August 2, 2007
Clinical and molecular genetics of patients with the Carney-Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHDBarbara Pasini, Sarah R McWhinney, Thalia Bei, et al.
Human Mutation|September 2, 2011
Extending the phenotypes associated with DICER1 mutationsWilliam D Foulkes, Amin Bahubeshi, Nancy Hamel, et al.
Molecular Cancer|April 30, 2017
PARP1 expression drives the synergistic antitumor activity of trabectedin and PARP1 inhibitors in sarcoma preclinical modelsYmera Pignochino, Federica Capozzi, Lorenzo D'Ambrosio, et al.
The Journal of Clinical Endocrinology and Metabolism|May 31, 2007
Genetics of carney triad: recurrent losses at chromosome 1 but lack of germline mutations in genes associated with paragangliomas and gastrointestinal stromal tumorsLudmila Matyakhina, Thalia A Bei, Sarah R McWhinney, et al.
Future Oncology (London, England)|June 1, 2016
Recommendations for the implementation of BRCA testing in the care and treatment pathways of ovarian cancer patientsCarmine Pinto, Maria Angela Bella, Ettore Capoluongo, et al.
Genes, Chromosomes & Cancer|October 20, 2018
Sensitivity to asbestos is increased in patients with mesothelioma and pathogenic germline variants in BAP1 or other DNA repair genesMarta Betti, Anna Aspesi, Daniela Ferrante, et al.
Parkinsonism & Related Disorders|March 29, 2025
LONG-NEXT: A new accurate and efficient NGS-based method for GBA1 analysis in Parkinson diseaseGiada Cuconato, Ilaria Palmieri, Marco Percetti, et al.
Diagnostics (Basel, Switzerland)|October 12, 2019
<i>BRCA1/2</i> Molecular Assay for Ovarian Cancer Patients: A Survey through Italian Departments of Oncology and Molecular and Genomic Diagnostic LaboratoriesEttore Capoluongo, Nicla La Verde, Massimo Barberis, et al.
Critical Reviews in Oncology/Hematology|June 9, 2019
Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relativesStefania Gori, Massimo Barberis, Maria Angela Bella, et al.
Pageof 10

Showing results (61-70 of 96) with videos related to

Sort By:
Pageof 10
American Journal of Medical Genetics|January 25, 2002
High prevalence of the G101W germline mutation in the CDKN2A (P16(ink4a)) gene in 62 Italian malignant melanoma familiesMichela Mantelli, Monica Barile, Paola Ciotti, et al.
European Journal of Human Genetics : EJHG|August 2, 2007
Clinical and molecular genetics of patients with the Carney-Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHDBarbara Pasini, Sarah R McWhinney, Thalia Bei, et al.
Human Mutation|September 2, 2011
Extending the phenotypes associated with DICER1 mutationsWilliam D Foulkes, Amin Bahubeshi, Nancy Hamel, et al.
Molecular Cancer|April 30, 2017
PARP1 expression drives the synergistic antitumor activity of trabectedin and PARP1 inhibitors in sarcoma preclinical modelsYmera Pignochino, Federica Capozzi, Lorenzo D'Ambrosio, et al.
The Journal of Clinical Endocrinology and Metabolism|May 31, 2007
Genetics of carney triad: recurrent losses at chromosome 1 but lack of germline mutations in genes associated with paragangliomas and gastrointestinal stromal tumorsLudmila Matyakhina, Thalia A Bei, Sarah R McWhinney, et al.
Future Oncology (London, England)|June 1, 2016
Recommendations for the implementation of BRCA testing in the care and treatment pathways of ovarian cancer patientsCarmine Pinto, Maria Angela Bella, Ettore Capoluongo, et al.
Genes, Chromosomes & Cancer|October 20, 2018
Sensitivity to asbestos is increased in patients with mesothelioma and pathogenic germline variants in BAP1 or other DNA repair genesMarta Betti, Anna Aspesi, Daniela Ferrante, et al.
Parkinsonism & Related Disorders|March 29, 2025
LONG-NEXT: A new accurate and efficient NGS-based method for GBA1 analysis in Parkinson diseaseGiada Cuconato, Ilaria Palmieri, Marco Percetti, et al.
Diagnostics (Basel, Switzerland)|October 12, 2019
<i>BRCA1/2</i> Molecular Assay for Ovarian Cancer Patients: A Survey through Italian Departments of Oncology and Molecular and Genomic Diagnostic LaboratoriesEttore Capoluongo, Nicla La Verde, Massimo Barberis, et al.
Critical Reviews in Oncology/Hematology|June 9, 2019
Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relativesStefania Gori, Massimo Barberis, Maria Angela Bella, et al.
Pageof 10